Alan Johnston joins Scottish Biomedical
This article was originally published in Scrip
Alan Johnston has joined Scottish Biomedical as a non-executive director. His career, spanning more than 32 years, has been in the development of new medicines at the CRO Inveresk Research (now Charles River Laboratories) in Edinburgh.
You may also be interested in...
New proposed rule says a manufacturer’s knowledge of the unapproved use of a product does not alone determine intended use. Former FDA lawyer says rule could set off fireworks over the scope of what the agency considers evidence of off-label use.
Private Company Edition: Also, Medicxi’s new €200m fund will be reinvested in a portfolio of six life science companies and Silverback more than doubled its 2020 money with an $85m series C round.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.